As Additional Drug Is Identified as Possible Cause of Meningitis Outbreak, Rottenstein Law Group Rev
The Rottenstein Law Group, which represents clients with claims stemming from dangerous prescription drugs and medical devices, is currently reviewing the cases of victims of the recent U.S. meningitis outbreak. New York (PRWEB) October 16, 2012 As the case count in the U.S. fungal meningitis outbreak exceeds 200, the Rottenstein Law Group is assessing the viability of the outbreak victims’ legal claims. The possibly tainted methylprednisolone steroid medication that caused the outbreak and has since been recalled was administered to 14,000 people, according to an October 15, 2012, New Y
Contributor
About
PRWeb, a leader in online news and press release distribution, has been used by attorneys, law firms and more than 40,000 organizations
PRWeb, a leader in online news and press release distribution, has been used by attorneys, law firms and more than 40,000 organizations
Categories
- Articles 313
- Bankruptcy 44
- Business 135
- Cases & Codes 68
- Contracts 27
- Criminal Law 122
- Employment 24
- Expert Reports 3
- Expert Witness 34
- Family Law 58
- Form Letters 15
- Immigration 3
- Intellectual Prop 32
- Internet Law 10
- Law Practice 99
- Law School 2
- Legal Research 19
- Litigation 186
- Miscellaneous 64
- PR Web 41689
- Personal Injury 609
- Press Release 43
- Probate 54
- Real Estate 68
- Tax Law 23
- Workers Comp 4